Amaryl 1mg Tablets
- Name:
Amaryl 1mg Tablets
- Company:
SANOFI
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 04/06/19
(Click to Download)Click on this link to Download PDF directly
SANOFI
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 4 June 2019 PIL
Reasons for updating
- Change to section 6 - manufacturer
Updated on 8 March 2019 PIL
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 8 March 2019 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Amaryl contains lactose monohydrate. Patients with rare hereditary problems of galactose intolerance, the Lapp total lactase deficiency or glucose‑galactose malabsorption should not take this medicine.
Updated on 22 November 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 22 November 2017 SPC
Reasons for updating
- Change to section 4.3 - Contraindications
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.7 - Effects on ability to drive and use machines
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
4.3 added :-
Diabetes mellitus type 1
4.3 removed :-
insulin dependent diabetes
4.6 added :-
Fertility,
Fertility
No data on fertility is available.
4.7 added :-
Rare: dysgeusia.
Rare: alopecia.
Rare: weight gain.
Updated on 21 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 21 November 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 20 January 2016 SPC
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 4 August 2015 SPC
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 31 July 2015 PIL
Reasons for updating
- Change to name of manufacturer
Updated on 25 October 2013 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Type II variation n° C.I.4 to update of Summary of Product Characteristics section 4.5 to include information on a drug interaction between glimepiride and colesevelam.
Updated on 23 October 2013 PIL
Reasons for updating
- Change to side-effects
Updated on 24 July 2013 SPC
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 4 - Clinical particulars
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 16 May 2013 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Type II Procedure variation n° C.I.4 Update of Summary of Product Characteristics to include the adverse reaction: ‘Severe thrombocytopenia with platelet count less than 10,000/µl and thrombocytopenic purpura’. Minor editorial updates to the SPC are also included.
Updated on 10 May 2013 PIL
Reasons for updating
- Change to side-effects
Updated on 17 September 2012 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 13 September 2012 PIL
Reasons for updating
- Introduction of new pack/pack size
Updated on 20 January 2011 PIL
Reasons for updating
- Change of manufacturer
Updated on 22 November 2010 SPC
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 10 November 2010 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 5.1 - Pharmacodynamic properties
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.5: Addition of a drug interaction with disopyramide
Section 4.4, 4.5 & 5.1: Typographical errors amended
Updated on 8 November 2010 PIL
Reasons for updating
- Change to drug interactions
Updated on 11 June 2010 SPC
Reasons for updating
- Improved electronic presentation
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 5 May 2010 SPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Section 4.8 - Information on frequency
Updated on 28 April 2010 PIL
Reasons for updating
- New PIL for medicines.ie
Updated on 11 September 2009 SPC
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 19 August 2008 SPC
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 19 August 2008 SPC
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 1 July 2008 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 26 March 2008 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)